| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that the equation t1/2 = VD / Cl * 0.693 was used | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| ENSARTINIB
| ENSARTINIB | ANTINEOPLASTIC | ORAL | Cmax 520 NANOMOLAR Tmax 3 HOUR VD 1720 LITER PPB 91.6 PERCENT HT 30 HOUR | ANAPLASTIC LYMPHOMA KINASE (ALK) MET ROS1 | - more at DrugCentral | EMA | |||
